Indeed, in the brain and cerebrospinal fluid (CSF) of AD patients, glycosylation of AChE enzymatic activity is altered [7] and expression of a particular AChE monomeric form with different glycosylation is increased [8,9]. This evidence concerns the gene ACHE and Alzheimer disease.